CompletedNot Applicable

Therapeutic Effects of Constraint-Induced Movement Therapy on Young Children With Cerebral Palsy

South Korea32 participantsStarted 2015-09-14

Plain-language summary

This study evaluates the therapeutic effects of constraint-induced movement therapy on infants and children with hemiplegic cerebral palsy. Half of the participants will receive CIMT (constraint-induced movement therapy) and others will not.

Who can participate

Age range7 Months – 36 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * spastic hemiplegic cerebral palsy patients * 7\~36 months old Exclusion Criteria: * cognitive impairment severe enough to make participation impossible * uncontrolled epilepsy * visual or hearing impairment * musculoskeletal disorders

What they're measuring

Change From Baseline Pediatric Motor Activity Log (PMAL) Score at Post Test

Timeframe: baseline and 4 weeks

Change From Baseline Accelerometers_Vector Magnitude Average Counts(VMA) at Post Test

Timeframe: baseline and 4 weeks

Trial details

NCT IDNCT03858335

SponsorSamsung Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-28

Results submitted2020-05-28

View on ClinicalTrials.gov More Cerebral Palsy Spastic Hemiplegic trials